Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Optinose Inc. maintains 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These matters are handled by 2 distinct examiners, yet they are contained within a distinct art unit. This structure suggests that while the company is interacting with different individuals, the technical focus remains consistent across a single administrative division of the patent office.
The busiest examiner, WOODWARD, VALERIE LYNN, is responsible for 1 busiest examiner pending action. With the workload split between examiners, the company must navigate different individual preferences while operating under the unified guidelines of one art unit. This balance requires a prosecution strategy that addresses the specific technical standards of the Medical Devices & Mechanical Engineering field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WOODWARD, VALERIE LYNN | 1 | 71.3% | +27.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18643434 | Nasal Administration | WOODWARD, VALERIE LYNN | — |
| Art Unit | Apps |
|---|---|
| 3785 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18643434 | Nasal Administration | WOODWARD, VALERIE LYNN | 3785 | §112DP | Non-Final OA | — | Pending | Apr 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOptinose Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Valerie Lynn Woodward has the most, with 1 of Optinose Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
